Arthur M. Cohen & Associates, LLC Amgen Inc Transaction History

Arthur M. Cohen & Associates, LLC

$548 Million
Q3 2024

A detailed history of Arthur M. Cohen & Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, Arthur M. Cohen & Associates, LLC holds 7,911 shares of AMGN stock, worth $2.09 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

7,911

Previous 7,911 -0.0%

Holding current value

$2.09 Million

Previous $2.47 Million 3.16%

% of portfolio

0.46%

Previous 0.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $26,275 - $31,931	-100 Reduced 1.25%	7,911 $2.47 Million
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $204,341 - $246,665	-760 Reduced 8.66%	8,011 $2.28 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $25,570 - $28,845	-100 Reduced 1.13%	8,771 $2.53 Million
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $248,823 - $308,921	-1,138 Reduced 11.37%	8,871 $2.38 Million
Q2 2023 Jul 19, 2023	SELL	$214.27 - $253.37 $115,705 - $136,819	-540 Reduced 5.12%	10,009 $2.22 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $69,994 - $85,312	310 Added 3.03%	10,549 $2.55 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $145,434 - $184,791	-635 Reduced 5.84%	10,239 $0
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $179,568 - $202,520	-800 Reduced 6.85%	10,874 $2.45 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $204,178 - $227,214	-885 Reduced 7.05%	11,674 $2.84 Million
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $1.97 Million - $2.18 Million	-8,990 Reduced 41.72%	12,559 $3.04 Million
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $647,354 - $740,838	-3,255 Reduced 13.12%	21,549 $4.84 Million
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $344,089 - $403,142	-1,621 Reduced 6.13%	24,804 $5.27 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $333,552 - $370,051	-1,428 Reduced 5.13%	26,425 $6.44 Million
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $224,129 - $261,186	-1,010 Reduced 3.5%	27,853 $6.93 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $23,801 - $28,343	-110 Reduced 0.38%	28,863 $6.64 Million
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $78,842 - $87,679	336 Added 1.17%	28,973 $7.36 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $90,201 - $110,689	-456 Reduced 1.57%	28,637 $6.75 Million
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $41,915 - $55,591	230 Added 0.8%	29,093 $5.76 Million
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $491,946 - $632,320	-2,600 Reduced 8.26%	28,863 $6.94 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $38,652 - $46,313	222 Added 0.71%	31,463 $6.09 Million
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $6.4 Million - $7.5 Million	-38,400 Reduced 55.14%	31,241 $5.76 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $427,395 - $481,768	-2,363 Reduced 3.28%	69,641 $13.7 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $287,014 - $323,570	1,549 Added 2.2%	72,004 $14.9 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $117,065 - $131,489	705 Added 1.01%	70,455 $13 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $648,069 - $757,350	-3,825 Reduced 5.2%	69,750 $11.6 Million
Q4 2017 Mar 06, 2019	BUY	$168.79 - $188.59 $11.3 Million - $12.6 Million	66,712 Added 972.05%	73,575 $14.3 Million
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $10.2 Million - $11.4 Million	-60,302 Reduced 89.78%	6,863 $11.9 Million
Q3 2014 Nov 08, 2017	BUY	N/A	67,165	67,165 $12.5 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.

Account

Arthur M. Cohen & Associates, LLC Amgen Inc Transaction History